Platelet function can be modified by cancer cells to support tumor growth, causing
alterations in the delicate hemostatic equilibrium. Cancer-cell and platelet interactions are …

Background: Extensive research has reported that extracellular ADP in the tumour
microenvironment can stimulate platelets through interaction with the platelet receptor …

Simple Summary Cancer-associated thrombosis is the first cause of death in cancer after
cancer-progression itself; however, thrombotic risk is not the same in all cancer types. Here …

Platelets, beyond their role in hemostasis and thrombosis, may sustain tumorigenesis and
metastasis. These effects may occur via direct interaction of platelets with cancer and …

Cancer-associated thrombosis is a common first presenting sign of malignancy and is
currently the second leading cause of death in cancer patients after their malignancy …

Background In cancer, platelets may facilitate metastatic spread by a number of mechanisms
as well as contribute to thrombotic complications. Ticagrelor, a platelet antagonist-that …

Venous thromboembolism (VTE) is one of the most common causes of cancer related
mortality. It has been speculated that hypercoagulation in cancer patients is triggered by …

Both platelets and the liver play important roles in the processes of coagulation and innate
immunity. Platelet responses at the site of an injury are rapid; their immediate activation and …

Both platelets and the liver play important roles in the processes of coagulation and innate
immunity. Platelet responses at the site of an injury are rapid; their immediate activation and …

Introduction The association between thrombosis, cancer and inflammation is well-
established. Platelets play a major role in atherosclerosis, inflammation and immune …